vs
Groupon, Inc.(GRPN)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
Groupon, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍($132.7M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 1.8%),Groupon, Inc.自由现金流更多($53.0M vs $14.4M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 3.8%)
Groupon股份有限公司是源自美国的电子商务平台,业务覆盖全球13个国家,主打本地生活服务领域,主打以团购优惠券的模式,连接消费者与本地商户,覆盖休闲活动、旅行、商品及各类生活服务等多个品类。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
GRPN vs PBYI — 直观对比
营收规模更大
GRPN
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出25.9%
1.8%
自由现金流更多
GRPN
多$38.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $132.7M | $75.5M |
| 净利润 | $7.9M | — |
| 毛利率 | 90.4% | 69.3% |
| 营业利润率 | 4.9% | 22.7% |
| 净利率 | 6.0% | — |
| 营收同比 | 1.8% | 27.7% |
| 净利润同比 | 115.8% | — |
| 每股收益(稀释后) | $0.21 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GRPN
PBYI
| Q4 25 | $132.7M | $75.5M | ||
| Q3 25 | $122.8M | $54.5M | ||
| Q2 25 | $125.7M | $52.4M | ||
| Q1 25 | $117.2M | $46.0M | ||
| Q4 24 | $130.4M | $59.1M | ||
| Q3 24 | $114.5M | $80.5M | ||
| Q2 24 | $124.6M | $47.1M | ||
| Q1 24 | $123.1M | $43.8M |
净利润
GRPN
PBYI
| Q4 25 | $7.9M | — | ||
| Q3 25 | $-118.4M | $8.8M | ||
| Q2 25 | $20.3M | $5.9M | ||
| Q1 25 | $7.2M | $3.0M | ||
| Q4 24 | $-50.1M | — | ||
| Q3 24 | $13.9M | $20.3M | ||
| Q2 24 | $-10.0M | $-4.5M | ||
| Q1 24 | $-12.3M | $-4.8M |
毛利率
GRPN
PBYI
| Q4 25 | 90.4% | 69.3% | ||
| Q3 25 | 91.1% | 77.7% | ||
| Q2 25 | 91.0% | 76.5% | ||
| Q1 25 | 90.7% | 77.1% | ||
| Q4 24 | 90.6% | 76.4% | ||
| Q3 24 | 89.9% | 63.9% | ||
| Q2 24 | 90.4% | 77.4% | ||
| Q1 24 | 89.8% | 75.5% |
营业利润率
GRPN
PBYI
| Q4 25 | 4.9% | 22.7% | ||
| Q3 25 | 1.8% | 17.6% | ||
| Q2 25 | 10.4% | 12.7% | ||
| Q1 25 | 1.6% | 8.7% | ||
| Q4 24 | 2.0% | 22.6% | ||
| Q3 24 | -4.9% | 27.4% | ||
| Q2 24 | 3.5% | -4.6% | ||
| Q1 24 | 6.0% | -5.3% |
净利率
GRPN
PBYI
| Q4 25 | 6.0% | — | ||
| Q3 25 | -96.4% | 16.2% | ||
| Q2 25 | 16.2% | 11.2% | ||
| Q1 25 | 6.1% | 6.5% | ||
| Q4 24 | -38.4% | — | ||
| Q3 24 | 12.2% | 25.2% | ||
| Q2 24 | -8.1% | -9.6% | ||
| Q1 24 | -10.0% | -11.0% |
每股收益(稀释后)
GRPN
PBYI
| Q4 25 | $0.21 | $0.26 | ||
| Q3 25 | $-2.92 | $0.17 | ||
| Q2 25 | $0.46 | $0.12 | ||
| Q1 25 | $0.17 | $0.06 | ||
| Q4 24 | $-1.26 | $0.40 | ||
| Q3 24 | $0.33 | $0.41 | ||
| Q2 24 | $-0.25 | $-0.09 | ||
| Q1 24 | $-0.33 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $296.1M | $97.5M |
| 总债务越低越好 | $342.8M | $22.7M |
| 股东权益账面价值 | $-42.6M | $130.3M |
| 总资产 | $670.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
GRPN
PBYI
| Q4 25 | $296.1M | $97.5M | ||
| Q3 25 | $238.5M | $94.4M | ||
| Q2 25 | $262.6M | $96.0M | ||
| Q1 25 | $226.8M | $93.2M | ||
| Q4 24 | $228.8M | $101.0M | ||
| Q3 24 | $159.7M | $96.7M | ||
| Q2 24 | $178.1M | $96.8M | ||
| Q1 24 | $158.7M | $107.2M |
总债务
GRPN
PBYI
| Q4 25 | $342.8M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $246.0M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
GRPN
PBYI
| Q4 25 | $-42.6M | $130.3M | ||
| Q3 25 | $-59.6M | $115.3M | ||
| Q2 25 | $51.2M | $104.7M | ||
| Q1 25 | $45.5M | $97.1M | ||
| Q4 24 | $40.8M | $92.1M | ||
| Q3 24 | $40.0M | $71.1M | ||
| Q2 24 | $40.2M | $48.5M | ||
| Q1 24 | $41.2M | $51.0M |
总资产
GRPN
PBYI
| Q4 25 | $670.4M | $216.3M | ||
| Q3 25 | $608.2M | $202.9M | ||
| Q2 25 | $647.4M | $194.9M | ||
| Q1 25 | $608.2M | $196.2M | ||
| Q4 24 | $612.7M | $213.3M | ||
| Q3 24 | $548.0M | $220.7M | ||
| Q2 24 | $572.8M | $205.0M | ||
| Q1 24 | $580.5M | $214.1M |
负债/权益比
GRPN
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 6.03× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $56.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $53.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 40.0% | 19.1% |
| 资本支出强度资本支出/营收 | 2.7% | 0.0% |
| 现金转化率经营现金流/净利润 | 7.13× | — |
| 过去12个月自由现金流最近4个季度 | $49.9M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
GRPN
PBYI
| Q4 25 | $56.6M | $14.4M | ||
| Q3 25 | $-20.5M | $9.7M | ||
| Q2 25 | $28.4M | $14.1M | ||
| Q1 25 | $-22.0K | $3.6M | ||
| Q4 24 | $67.0M | $15.6M | ||
| Q3 24 | $-16.3M | $11.0M | ||
| Q2 24 | $15.3M | $1.0M | ||
| Q1 24 | $-10.1M | $11.2M |
自由现金流
GRPN
PBYI
| Q4 25 | $53.0M | $14.4M | ||
| Q3 25 | $-24.6M | $9.7M | ||
| Q2 25 | $25.2M | $14.1M | ||
| Q1 25 | $-3.8M | $3.6M | ||
| Q4 24 | $63.2M | $15.6M | ||
| Q3 24 | $-19.7M | $11.0M | ||
| Q2 24 | $10.8M | $1.0M | ||
| Q1 24 | $-13.8M | — |
自由现金流率
GRPN
PBYI
| Q4 25 | 40.0% | 19.1% | ||
| Q3 25 | -20.0% | 17.7% | ||
| Q2 25 | 20.0% | 26.8% | ||
| Q1 25 | -3.2% | 7.7% | ||
| Q4 24 | 48.5% | 26.4% | ||
| Q3 24 | -17.2% | 13.7% | ||
| Q2 24 | 8.7% | 2.1% | ||
| Q1 24 | -11.2% | — |
资本支出强度
GRPN
PBYI
| Q4 25 | 2.7% | 0.0% | ||
| Q3 25 | 3.3% | 0.0% | ||
| Q2 25 | 2.6% | 0.0% | ||
| Q1 25 | 3.2% | 0.1% | ||
| Q4 24 | 2.9% | 0.0% | ||
| Q3 24 | 3.0% | 0.0% | ||
| Q2 24 | 3.6% | 0.0% | ||
| Q1 24 | 3.0% | 0.0% |
现金转化率
GRPN
PBYI
| Q4 25 | 7.13× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 1.40× | 2.41× | ||
| Q1 25 | -0.00× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.17× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GRPN
| Service Local | $94.8M | 71% |
| Other | $35.6M | 27% |
| Service Travel | $2.3M | 2% |
PBYI
暂无分部数据